MarketFriction

Krishna Institute of Medical Sciences Ltd

NSE KIMS · BSE 543308 · Hospital
₹736.25 -1.36%
NSE close2026-10-01
52 week range575.80 - 858.00
Market cap₹32,336 Cr.
P/E155
Nifty 500Smallcap 250Nifty Healthcare Index Price band 20% Delivery 63.8%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales6526066346887777727978729619981,0751,180
Expenses475459475509559585599679757799868956
Operating Profit177147159179218187198193204199206223
OPM %27%24%25%26%28%24%25%22%21%20%19%19%
Other Income334551815745117
Interest91216182026273345576883
Depreciation3335463941455353667985101
Profit before tax13910210012716213513411497695557
Tax %27%25%28%25%26%31%21%25%26%24%40%34%
Net Profit101777295121921068572523337
EPS in Rs2.301.801.642.162.682.222.541.961.671.331.060.99
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5125676649181,1231,3301,6512,1982,4983,0353,9054,212
Expenses4034505938338729531,1261,5871,8502,2423,0903,380
Operating Profit1091187185251377524611648793815833
OPM %21%21%11%9%22%28%32%28%26%26%21%20%
Other Income5337659274113431728
Interest373288494437223755100215253
Depreciation36354056717073129147177283331
Profit before tax4153-20-15141279457485460558334277
Tax %32%37%126%223%18%26%25%25%27%26%28%
Net Profit2833-46-49115205344366336415242194
EPS in Rs0.760.91-1.32-1.283.205.198.328.417.759.616.035.05
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth23%24%21%31%
Compounded Profit Growth25%4%-9%-43%
Stock Price CAGR%26%25%10%
Return on Equity18%18%15%11%
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital7072507474788080808080
Reserves193255-2094665247861,3071,5901,7482,0582,167
Borrowings2562807533363693162576781,3552,5624,253
Other Liabilities1461673592372282532605536369901,190
Total Liabilities6657749541,1141,1941,4331,9042,9013,8205,6897,691
Fixed Assets5155187558639169311,0051,7662,4343,3485,710
CWIP2640029214776001,214606
Investments111400003326815799103
Other Assets1371771992502764935465906291,0281,271
Total Assets6657749541,1141,1941,4331,9042,9013,8205,6897,691
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity9582106134202356324432521582511
Cash from Investing Activity-41-100-64-110-125-354-412-416-753-1,116-1,452
Cash from Financing Activity-6524-39-27-44106120217543940
Net Cash Flow-1153-33212-2636-159-1
Free Cash Flow61-184957150262154-140-125-380-902
CFO/OP88%80%192%195%102%104%86%87%102%91%81%
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days4759594943302842434852
Inventory Days36434647443037
Days Payable194207215181177167133
Cash Conversion Cycle-111-105-110-85-91-106-6742434852
Working Capital Days1126-333-15-15-31-38-5-29-37
ROCE %15%11%5%20%29%34%24%17%15%10%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters38.85%38.82%38.82%38.82%38.82%38.82%38.82%34.11%34.11%34.11%34.11%32.49%
FIIs14.24%15.27%16.73%17.84%15.85%15.68%15.44%15.54%15.03%14.33%14.57%14.75%
DIIs34.80%34.24%33.13%32.12%32.29%32.05%31.95%31.65%32.12%32.72%32.50%34.42%
Public12.10%11.67%11.32%11.22%13.03%13.45%13.78%18.68%18.74%18.85%18.82%18.32%
No. of Shareholders66,95771,01469,09269,06377,61795,4681,01,8951,08,9551,04,8721,01,59993,33394,730

Fundamentals

Market Cap₹ 32,336 Cr.
Current Price₹ 770
Stock P/E155
Book Value₹ 56.2
ROCE9.50 %
ROE11.3 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)31%
Compounded Profit Growth (TTM)-43%
Consolidated figures.
Valuation
Market capRs 29,460 Cr
Enterprise valueRs 33,638 Cr
P/E (TTM)144.20x
Price to book13.11x
Price to sales6.99x
EV / EBITDA39.08x
EV / EBIT63.46x
EV / sales7.99x
Price to cash flow57.67x
Earnings yield0.69%
P/E, 3-year average60.07x
P/B, 3-year average8.28x
P/E, 5-year average38.71x
P/B, 5-year average5.56x
Profitability
Operating margin (excl. other income)20.88%
Operating margin (incl. other income)21.31%
EBITDA margin20.43%
Pre-tax margin6.57%
Net profit margin4.85%
Net margin, latest quarter3.52%
ROE11.01%
ROCE9.80%
ROA3.61%
ROE, 3-year average16.04%
ROCE, 3-year average15.03%
ROA, 3-year average6.97%
ROE, 5-year average19.94%
ROCE, 5-year average21.03%
ROA, 5-year average10.97%
ROIC (approx.)5.98%
Tax rate27.52%
Other income / net worth0.76%
Growth
Sales growth (latest year)28.65%
Profit growth (latest year)-37.22%
Sales CAGR, 3 years21.12%
Sales CAGR, 5 years24.04%
Profit CAGR, 3 years-10.46%
Profit CAGR, 5 years3.71%
Sales growth QoQ9.76%
Profit growth QoQ-2.35%
Sales growth YoY (latest quarter)35.33%
Profit growth YoY (latest quarter)-47.20%
Per share
EPS (TTM)Rs 5.11
EPS (latest year)Rs 6.03
EPS (latest quarter)Rs 1.04
EPS, 3-year averageRs 18.13
EPS, 5-year averageRs 27.60
Book value per shareRs 56.17
Sales per shareRs 105.28
Cash flow per shareRs 12.77
Free cash flow per shareRs -22.54
Efficiency
Asset turnover0.51x
Fixed asset turnover0.68x
Inventory turnover22.84x
Inventory days16 days
Debtor days52 days
Debtors turnover7.05x
Creditor days133 days
Cash conversion cycle52 days
Working capital days-37 days
Leverage
Total debtRs 4,253 Cr
Cash and bankRs 75 Cr
Net debtRs 4,178 Cr
Debt to equity1.89x
Net debt / EBITDA4.85x
Interest coverage2.09x
Current ratio (filing 2026-03-31)0.76x
Quick ratio (filing 2026-03-31)0.68x
Trade payables (filing 2026-03-31)Rs 323 Cr
Owners' fund to total sources29.22%
Debt to assets55.30%
Cash flow
Cash from Operating Activity (latest year)Rs 511 Cr
Cash from Investing Activity (latest year)Rs -1,452 Cr
Cash from Financing Activity (latest year)Rs 940 Cr
Net Cash Flow (latest year)Rs -1 Cr
Free cash flow (latest year)Rs -902 Cr
FCFE (approx.: FCF + change in debt)Rs 789 Cr
Cash from ops / profit, 5 years1.39x
Sales to cash flow7.64x
Statement figures
Net sales (TTM)Rs 4,212 Cr
Net sales (latest year)Rs 3,905 Cr
Sales (latest quarter)Rs 1,180 Cr
Operating profit excl. other income (latest year)Rs 815 Cr
Operating profit (latest quarter)Rs 223 Cr
Other income (TTM)Rs 28 Cr
EBITDA (TTM)Rs 861 Cr
PBDT (TTM)Rs 607 Cr
Profit before tax (TTM)Rs 277 Cr
Tax (latest year)Rs 92 Cr
Net profit (TTM)Rs 204 Cr
Net profit (latest year)Rs 241 Cr
Net profit (latest quarter)Rs 42 Cr
Depreciation (TTM)Rs 331 Cr
Depreciation (latest quarter)Rs 101 Cr
Interest (TTM)Rs 253 Cr
Cost of goods sold (latest year)Rs 2,213 Cr
Total expenditure (latest year)Rs 3,090 Cr
Total income (latest year)Rs 3,922 Cr
Share capitalRs 80 Cr
ReservesRs 2,167 Cr
Shareholders' fundsRs 2,247 Cr
Total assetsRs 7,691 Cr
Net blockRs 5,710 Cr
Capital work in progressRs 606 Cr
InvestmentsRs 103 Cr
ReceivablesRs 554 Cr
InventoryRs 97 Cr
Other liabilitiesRs 1,190 Cr
Shares outstanding (crore)40.01
Ownership
Promoter holding32.49% (-1.62 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 144.2 is at the 95th percentile of its own 5.4-year range (median 53.6, low 28.5, high 148.0).
P/B 13.11 is at the 77th percentile (median 11.39).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodKIMSNifty 50Difference
1 week-8.0%-2.8% -5.2 pts
1 month-2.9%-6.8% +3.9 pts
3 months-13.4%-7.6% -5.8 pts
6 months+18.5%+0.4% +18.1 pts
1 year+0.5%-9.9% +10.4 pts
2 years+35.3%-13.6% +48.8 pts
3 years+86.2%+14.2% +72.0 pts
5 years+203.7%+27.9% +175.8 pts
149 mutual fund schemes hold about ₹9,641 Cr. Over three months 25 bought more and 62 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
HDFC Small Cap Fund2.01%841 +3%
SBI Small Cap Fund1.95%831 -10%
Axis Small Cap Fund2.43%765 +0%
Kotak Small Cap Fund3.25%639 +2%
Invesco India Smallcap Fund3.54%558 -9%
SBI Multicap Fund2.00%491 +4%
Nippon India Small Cap Fund0.56%462 +2%
Axis Flexi Cap Fund2.94%410 +2%
Axis Flexi Cap Fund2.94%397 +2%
HDFC Aggressive Hybrid Fund1.42%317 +8%
Kotak Flexi Cap Fund0.44%249 +225%
Kotak Flexi Cap Fund0.44%248 +225%
Invesco India Large & Mid Cap Fund1.49%175 -3%
Axis ELSS-Tax Saver Fund0.52%170 +79%
Invesco India Midcap Fund0.92%146 -7%
Edelweiss Small Cap Fund1.83%133 -3%
HSBC Small Cap Fund0.65%124 +0%
ICICI Pru Small Cap Fund1.17%115 +52%
Mirae Asset Healthcare Fund3.16%112 -5%
ICICI Pru Small Cap Fund1.17%112 +52%
Kotak Business Cycle Fund3.18%112 +1%
Invesco India Multicap Fund2.29%104 +2%
Kotak Focused Fund2.27%103 +1%
SBI Healthcare Opp Fund1.74%101 -8%
SBI ELSS Tax Saver Fund0.32%100 +7%

Red flags

F-score 4 of 8
explainDebt up, profit down Borrowings up 66% while net profit fell in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Insider trades

NSE insider and takeover-code disclosures
DateWhoRoleSideSharesValueHow
2026-09-18Catalyst Trusteeship Limited actinAcquirerbuy2,808,979SAST Others
2024-09-24Bhaskara Rao BollineniPromotersother670,000Rs 35.00 CrRevokation of Pledge
2024-06-14Bhaskara Rao BollineniPromotersother34,000Rs 7.00 CrRevokation of Pledge
2024-06-14Bhaskara Rao BollineniPromotersother103,000Rs 21.00 CrRevokation of Pledge
2024-06-14Bhaskara Rao BollineniPromotersother42,000Rs 8.50 CrRevokation of Pledge
2024-05-31Bhaskara Rao BollineniPromotersother34,000Rs 6.00 CrPledge Creation
2024-05-31Bhaskara Rao BollineniPromotersother103,000Rs 19.00 CrPledge Creation
2024-05-31Bhaskara Rao BollineniPromotersother42,000Rs 8.00 CrPledge Creation
2024-02-28Bhaskara Rao BollineniPromotersother96,000Rs 22.00 CrPledge Creation
2024-02-28Bollineni Seenaiah NaiduPromoter Groupother174,000Rs 40.00 CrPledge Creation
2024-02-27Bhaskara Rao BollineniPromotersother76,000Rs 17.42 CrRevokation of Pledge
2024-02-27Bollineni Seenaiah NaiduPromoter Groupother140,000Rs 32.08 CrRevokation of Pledge
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.

Latest quarter

Jun 2026
Sales ₹1,180 Cr +35.3% vs Jun 2025. Net profit ₹37 Cr -56.5%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Apollo Hospitals Enterprise Ltd124,50359.217.4 %
Manipal Health Enterprises Ltd98,35711112.1 %
Max Healthcare Institute Ltd95,58963.814.7 %
Aster DM Quality Care Ltd63,97617711.6 %
Fortis Healthcare Ltd62,05858.213.4 %
Global Health Ltd38,04866.417.4 %
Narayana Hrudayalaya Ltd36,57942.415.5 %
Dr Agarwals Health Care Ltd15,70110610.9 %
Rainbow Childrens Medicare Ltd13,89248.517.4 %
Park Medi World Ltd11,89842.819.5 %
Yatharth Hospital & Trauma Care Services Ltd10,67658.912.9 %
Healthcare Global Enterprises Ltd10,5052188.30 %
Jupiter Life Line Hospitals Ltd8,59144.914.8 %
Kovai Medical Center & Hospital Ltd6,57925.722.6 %
Artemis Medicare Services Ltd5,81850.414.5 %
No bulk or block deals on record.
Ex-dateActionFactor
2024-09-13Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share0.2000
DateTypeWhat it says
2026-09-15Concall / analyst meetSchedule of meet
2026-09-15Concall / analyst meetSchedule of meet
2026-09-10AgreementsEntering into an Operations and Management Agreement with Sarvottam Health Care Private Limited, Kakinada, Andhra Pradesh
2026-09-07Concall / analyst meetSchedule of meet
2026-08-30Shareholder meetingVoting results.
2026-08-27Shareholder meetingProceedings of Annual General Meeting held on August 27, 2026
2026-08-26General UpdatesClarification regarding article appearing in Dealstreetasia.com dated 25th August 2026 titled ChrysCapital- backed KIMS in talks to acquire stake in ...
2026-08-20AgreementsEntering into an Operations and Management Agreement and Call Option Agreement with Aurevia Hospitals Private Limited (Formerly known as Golden Lan So...
2026-08-20AllotmentAllotment of 7702182 fully convertible warrants securities pursuant to Preferential Issue
2026-08-08Concall / analyst meetTranscript
2026-08-07General UpdatesIntimation of receipt of the In-principle Approval from BSE Limited and the National Stock Exchange of India Limited for the issue and allotment of 77...
2026-08-05General UpdatesThe dispatched letter to those Members whose email addresses are not registered with Company/ Registrarand Transfer Agent/ Depositories, providing the...
2026-08-05UpdatesBRSR.
2026-08-05UpdatesSubmission of Annual Report for the FY 2025-26..
2026-08-05Shareholder meetingNotice of Annual General Meeting to be held on August 27, 2026
2026-08-04Concall / analyst meetLink of Recording
2026-08-04Concall / analyst meetSchedule of meet
2026-08-03Monitoring Agency ReportMonitoring Agency Report for the quarter ended June 30, 2026
2026-08-03Statement of deviation(s) orStatement of deviation(s) or variation(s) under Reg. 32
2026-08-03Press ReleaseA press release dated August 03, 2026, titled "Press Release Q1FY27".
2026-08-03Investor PresentationInvestor Presentation
2026-08-03Board meeting outcomeKrishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-28Concall / analyst meetSchedule of meet
2026-07-11Shareholder meetingVoting results.
2026-07-09Shareholder meetingProceedings of Extraordinary General Meeting held on July 09, 2026
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Krishna Institute of Medical Sciences Ltd?

Krishna Institute of Medical Sciences Ltd (KIMS) has a market capitalisation of Rs 32,336 Cr. at the 2026-10-01 close.

What is the P/E ratio of Krishna Institute of Medical Sciences Ltd?

Krishna Institute of Medical Sciences Ltd trades at a P/E of 155 on trailing twelve-month profit, at the 2026-10-01 close.

What were Krishna Institute of Medical Sciences Ltd's latest quarterly results?

In the Jun 2026 quarter, Krishna Institute of Medical Sciences Ltd sales was Rs 1,180 Cr (+35.3% vs Jun 2025) and net profit was Rs 37 Cr.

What is the 52-week high and low of Krishna Institute of Medical Sciences Ltd?

The 52-week high is Rs 858.00 and the 52-week low is Rs 575.80.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03